|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shao P, Liu Q, Maina PK, Cui J, Bair TB,
Li T, Umesalma S, Zhang W and Qi HH: Histone demethylase PHF8
promotes epithelial to mesenchymal transition and breast
tumorigenesis. Nucleic Acids Res. 45:1687–1702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu R, Shi P, Nie Z, Liang H, Zhou Z, Chen
W, Chen H, Dong C, Yang R, Liu S and Chen C: Mifepristone
suppresses basal triple-negative breast cancer stem cells by
down-regulating KLF5 expression. Theranostics. 6:533–544. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koufaris C, Valbuena GN, Pomyen Y,
Tredwell GD, Nevedomskaya E, Lau CH, Yang T, Benito A, Ellis JK and
Keun HC: Systematic integration of molecular profiles identifies
miR-22 as a regulator of lipid and folate metabolism in breast
cancer cells. Oncogene. 35:2766–2776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu H, Huang L, Zhu S, Li X, Li Z, Yu C
and Yu X: Regulation of autophagy by systemic admission of
microRNA-141 to target HMGB1 in l-arginine-induced acute
pancreatitis in vivo. Pancreatology. 16:337–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trümbach D and Prakash N: The conserved
miR-8/miR-200 microRNA family and their role in invertebrate and
vertebrate neurogenesis. Cell Tissue Res. 359:161–177. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Li L, Li Y and Liu Z: MiR-153
promotes breast cancer cell apoptosis by targeting HECTD3. Am J
Cancer Res. 6:1563–1571. 2016.PubMed/NCBI
|
|
12
|
Wang DS, Zhang HQ, Zhang B, Yuan ZB, Yu
ZK, Yang T, Zhang SQ, Liu Y and Jia XX: miR-133 inhibits pituitary
tumor cell migration and invasion via down-regulating FOXC1
expression. Genet Mol Res. 15:2016.(doi: 10.4238/gmr.15017453).
|
|
13
|
Li X, Li Y and Lu H: MiR-1193 suppresses
proliferation and invasion of human breast cancer cells through
directly targeting IGF2BP2. Oncol Res. 25:579–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye ZB, Ma G, Zhao YH, Xiao Y, Zhan Y, Jing
C, Gao K, Liu ZH and Yu SJ: miR-429 inhibits migration and invasion
of breast cancer cells in vitro. Int J Oncol. 46:531–538. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Hu X, Xia D and Zhang S:
MicroRNA-181b is downregulated in non-small cell lung cancer and
inhibits cell motility by directly targeting HMGB1. Oncol Lett.
12:4181–4186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhi F, Wang Q, Deng D, Shao N, Wang R, Xue
L, Wang S, Xia X and Yang Y: MiR-181b-5p downregulates NOVA1 to
suppress proliferation, migration and invasion and promote
apoptosis in astrocytoma. PLoS One. 9:e1091242014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bisso A, Faleschini M, Zampa F, Capaci V,
De Santa J, Santarpia L, Piazza S, Cappelletti V, Daidone M, Agami
R and Del Sal G: Oncogenic miR-181a/b affect the DNA damage
response in aggressive breast cancer. Cell Cycle. 12:1679–1687.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoo JO, Kwak SY, An HJ, Bae IH, Park MJ
and Han YH: miR-181b-3p promotes epithelial-mesenchymal transition
in breast cancer cells through Snail stabilization by directly
targeting YWHAG. Biochim Biophys Acta. 1863:1601–1611. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: MiR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taylor MA, Sossey-Alaoui K, Thompson CL,
Danielpour D and Schiemann WP: TGF-β upregulates miR-181a
expression to promote breast cancer metastasis. J Clin Invest.
123:150–163. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niu J, Xue A, Chi Y, Xue J, Wang W, Zhao
Z, Fan M, Yang CH, Shao ZM, Pfeffer LM, et al: Induction of
miRNA-181a by genotoxic treatments promotes chemotherapeutic
resistance and metastasis in breast cancer. Oncogene. 35:1302–1313.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neel JC and Lebrun JJ: Activin and TGFβ
regulate expression of the microRNA-181 family to promote cell
migration and invasion in breast cancer cells. Cell Signal.
25:1556–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sochor M, Basova P, Pesta M, Dusilkova N,
Bartos J, Burda P, Pospisil V and Stopka T: Oncogenic microRNAs:
miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early
breast cancer in serum. BMC Cancer. 14:4482014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li M, Zhang H, Zhao X, Yan L, Wang C and
Li C and Li C: SPRY4-mediated ERK1/2 signaling inhibition abolishes
17β-estradiol-induced cell growth in endometrial adenocarcinoma
cell. Gynecol Endocrinol. 30:600–604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun M, Huang F, Yu D, Zhang Y, Xu H, Zhang
L, Li L, Dong L, Guo L and Wang S: Autoregulatory loop between
TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma
modulates proliferation and differentiation. Cell Death Dis.
6:e18592015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou X, Xie S, Yuan C, Jiang L, Huang X,
Li L, Chen Y, Luo L, Zhang J, Wang D, et al: Lower expression of
SPRY4 predicts a poor prognosis and regulates cell proliferation in
colorectal cancer. Cell Physiol Biochem. 40:1433–1442. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vanas V, Mühlbacher E, Kral R and
Sutterlüty-Fall H: Sprouty4 interferes with cell proliferation and
migration of breast cancer-derived cell lines. Tumour Biol.
35:4447–4456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jing H, Liaw L, Friesel R, Vary C, Hua S
and Yang X: Suppression of Spry4 enhances cancer stem cell
properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell
Int. 16:192016. View Article : Google Scholar : PubMed/NCBI
|
